AKT1 and cancer: The major pathways involved include cancer, hepatitis B, and PI3K-Akt signaling pathway, which ultimately inhibit the growth of liver nodular in patients with chronic hepatitis B, impede the migration and proliferation ability of tumor cells, and promote the apoptosis of HepAD38 cells.